Answers are grounded in this paper and cite their sources.
Iron oxide nanoparticles (IONPs) are emerging as powerful tools in precision oncology, offering integrated capabilities for diagnosis, targeted therapy, and disease monitoring. This review focuses on magnetic IONPs, highlighting their application in targeted drug delivery, magnetic hyperthermia, and magnetic resonance imaging (MRI). We discuss synthesis methods and surface engineering strategies that improve tumor specificity, circulation stability, and biocompatibility. The main emphasis is placed on how physicochemical properties—such as size, shape, and surface charge—govern biodistribution, cellular uptake, and therapeutic performance. We also examine clinical progress, including FDA-approved IONP-based formulations, and assess their potential for wider medical adoption. Finally, the review outlines current barriers, including toxicity concerns, clearance pathways, and regulatory complexities, while pointing toward future directions such as smart responsive systems, combination therapies, and personalized nanomedicine. By mapping the present landscape alongside future opportunities, this work underscores the transformative role of IONPs in advancing cancer diagnosis and treatment.
No takes yet. Share an insight, caveat, or question.
A 2025 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: